Ramesh Hariharan

Corporate Officer/Principal at NATERA, INC.

Consumer Services

Health Services

Health Technology

Profile

Dr. Ramesh Hariharan is a General Manager-Women's Health at Natera, Inc. Dr. Hariharan was previously employed as a Vice President-Marketing by Biotheranostics, Inc. He received his undergraduate degree from Indian Institute of Technology Bombay, an MBA from Mit Solan School of Management and a doctorate degree from Princeton University.

Ramesh Hariharan active positions

Companies	Position	Start
NATERA, INC.	Corporate Officer/Principal	-

All active positions of Ramesh Hariharan

Former positions of Ramesh Hariharan

Companies	Position	End
Biotheranostics, Inc. Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.	Sales & Marketing	01/04/2016

See the detail of Ramesh Hariharan's experience

Training of Ramesh Hariharan

Indian Institute of Technology Bombay	Undergraduate Degree
Princeton University	Doctorate Degree
Mit Solan School of Management	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ramesh Hariharan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NATERA, INC.	Health Technology

Private companies	1
Biotheranostics, Inc. Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA.	Health Services